Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions The Weekly Buzzing Stocks by Billy Kawasaki
ImmunityBioIBRXTOP PICKFeb 19, 2026
$7.82
Stock price when the opinion was issued
$7.10
As of Jun 12, 2026. Market Open.
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentTOP PICK
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA. Social media mentions are up 31% in the past 24h.
In the last quarter, the company reported -0.07 USD per share, beating the -0.11 USD estimate by 34.66%. Revenue for the same period reached 32.06 M USD, despite the estimate of 31.88 M USD. For the next quarter, analysts expect -0.09 USD in earnings per share and 37.88 M USD in revenue. Social media mentions are up 1250% in the past 24h.